Markus Lundgren
41 – 50 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes : Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S
- Contribution to journal › Article
-
Mark
Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies : Beyond a Simple Count
- Contribution to journal › Scientific review
- 2020
-
Mark
First European Case of Simultaneous Liver and Pancreas Transplantation as Treatment of Wolcott-Rallison Syndrome in a Small Child
- Contribution to journal › Article
-
Mark
Parental anxiety after 5 years of participation in a longitudinal study of children at high risk of type 1 diabetes
- Contribution to journal › Article
-
Mark
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
- Contribution to journal › Article
-
Mark
Decreased HLA-DQ expression on peripheral blood cells in children with varying number of beta cell autoantibodies
- Contribution to journal › Article
-
Mark
Predicting Type 1 Diabetes Onset using Novel Survival Analysis with Biomarker Ontology
- Contribution to journal › Article
- 2019
-
Mark
Effect of screening for type 1 diabetes on early metabolic control : the DiPiS study
- Contribution to journal › Article
-
Mark
Practical management in Wolcott-Rallison syndrome with associated hypothyroidism, neutropenia, and recurrent liver failure : A case report
- Contribution to journal › Article
-
Mark
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk : The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
- Contribution to journal › Article
